Researchers report the development of a mouse model of Fukuyama's muscular dystrophy that copies the pathology seen in the human form of the disease. Muscular dystrophy is a complicated set of genetic ...

A multidisciplinary team, usually led by a neurologist, treats muscular dystrophy (MD). They’ll tailor the type of treatment you receive to your specific needs. MD is a group of conditions that lead ...

In human biology, the protein dystrophin is a shining example of Joni Mitchell’s classic line, “you don’t know what you’ve got ’til it’s gone.” Dystrophin stabilizes muscle cells. In its absence, the ...

Muscular dystrophy (MD) is a group of genetic disorders that damage muscle fibers and cause progressive weakness. Multiple sclerosis (MS) is an immune-mediated disease that affects the brain, spinal ...

A study by Indiana University School of Medicine researchers sheds new light on the development and treatment of a rare form of muscular dystrophy. The study's findings were recently published in ...

A person may inherit the genetic changes responsible for muscular dystrophy. These genetic changes can also occur due to spontaneous genetic mutations. In either case, the disease is not preventable.

TORONTO--(BUSINESS WIRE)--Satellos Bioscience Inc. (“Satellos” or the “Company”) (TSXV: MSCL) (OTCQB: MSCLF), a publicly traded biotech company developing new small molecule therapeutic approaches to ...

While scientists have identified one protein, dystrophin, as an important piece to curing muscular dystrophy, another part of the mystery has eluded scientists for the past 14 years. Now, scientists ...

Dystroglycan, a muscle cell receptor whose dysfunction causes muscular dystrophy, actually has a critical role in brain development, researchers have discovered. Researchers at Stony Brook University ...

BOULDER, Colo.--(BUSINESS WIRE)--Edgewise Therapeutics, a clinical-stage biopharmaceutical company developing orally bioavailable, small molecule therapies for musculoskeletal diseases, today ...

COLUMBUS, Ohio--(BUSINESS WIRE)--Forge Biologics, a member of Ajinomoto Bio-Pharma Services and leading manufacturer of genetic medicines, today announced it will be the adeno-associated virus (AAV) ...